Skip to content
All news
General

Morgan Stanley Announces $20B Buyback, 15% Dividend Hike

Morgan Stanley raised its quarterly dividend by 15% and reauthorized a $20 billion stock buyback shortly after clearing the Federal Reserve's 2026 stress test, according to a press release. The announcement arrived alongside similar capital return moves from JPMorgan Chase and Goldman Sachs.

July 3, 2026
2 min read
Source: TheStreet
Share:

Key Numbers

buyback
20B
dividend increase
15%

Morgan Stanley (NYSE: MS) announced a 15% increase in its quarterly dividend and reauthorized a $20 billion stock buyback program shortly after passing the Federal Reserve's 2026 stress test, according to a company press release.

Details of the Announcement

  • Stock Buyback: The board approved a new $20 billion share repurchase program.
  • Dividend Increase: The bank raised its quarterly dividend by 15%, though the exact new per-share amount was not disclosed.
  • Timing: The announcement came days after the Federal Reserve released stress test results showing Morgan Stanley has sufficient capital to withstand severe economic scenarios.

Context

This announcement is part of a wave of capital return plans from major banks. JPMorgan Chase and Goldman Sachs also announced similar dividend increases and buyback programs after passing the stress test. These moves reflect strong confidence in the banking sector's health and its ability to generate excess capital.

What This Means for Investors

The massive buyback program signals management's confidence in the stock's intrinsic value, while the dividend increase underscores the bank's commitment to returning capital to shareholders. However, investors should monitor how these programs are funded and their impact on future capital ratios.

Frequently Asked Questions

The new buyback program is $20 billion.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.